Outcomes Research: Key issues for healthcare industries

Outcomes Research: Key issues for healthcare industries

Outcomes Research: Key issues for healthcare industries is a combined strategic and practical guide from Scrip Reports explaining how to incorporate and utilise outcomes research. It will help you to understand precisely: how to manage outcomes research within your organisation; how to use outcomes research to make effective decisions; where to find outcomes data and which data is relevant.

Producing outcomes information for customers is now a commercial necessity and affects almost every department within your company. The data provided by this report is important for senior management and all personnel involved in marketing, R&D, pricing, outcomes research, health economics, portfolio management and corporate image.

This report includes: a checklist to assess the feasibility of outcomes projects; approaches for integrating outcomes research into marketing, R&D and pricing; how to manage outcomes research and health economic information; and how companies target their outcomes research, both internally and externally.

TABLE OF COTENTS

CHAPTER 1 INTRODUCTION
1.1 What is outcomes research?
1.2 From clinical trials to outcomes research, to health economics
1.2.1 Types of outcomes research studies
1.3 Skills of the outcomes professional
1.4 Applications of outcomes research
1.5 Hospital and industry viewpoints on outcomes data
1.6 The growth of outcomes research within pharmaceutical, biotechnology and medical device companies
1.7 Balancing patient clinical outcomes and costs
1.8 Outcomes research and disease management
1.9 Summary and outline of report

CHAPTER 2 STRATEGIC APPLICATIONS OF OUTCOMES RESEARCH
2.1 Introduction
2.2 Growth in importance of outcomes research
2.3 Strategic applications of outcomes research: how companies target their outcomes research and economic studies
2.4 Internal logistics
2.5 Strategic planning and outcomes research/health economic studies
2.6 Government attitudes to outcomes research and to health economics studies
2.7 Company checklist for feasibility of outcomes research
2.8 Addressing internal and external requirements for outcomes data
2.9 Outcomes research project planning
2.10 Establishing an outcomes research policy
2.11 Organisational structure of the outcomes department and manpower required
2.12 Conclusions

CHAPTER 3 WHICH CUSTOMERS NEED OUTCOMES RESEARCH INFORMATION?
3.1 Introduction
3.2 Perspective
3.2.1 Large purchasers and providers of healthcare
3.2.1.1 Outcomes case study - industry co-operation with healthcare providers
3.2.1.2 Communicating health economics results to large-scale purchasers and providers
3.2.2 Hospital clinicians
3.2.3 Pharmacists
3.2.4 Small group practices, and general practitioners
3.2.5 Patients
3.3 Viewpoints
3.4 The decision process of customers
3.5 What lessons can companies learn in conducting and disseminating outcomes research studies?

CHAPTER 4 OUTCOMES RESEARCH AND R&D PROGRAMMES
4.1 Integration of outcomes research into R&D programmes
4.2 Key issues of integrating outcomes research and health economics into R&D programmes
4.3 Integration of quality of life measures into R&D programmes
4.4 Outcomes research and health economics - problem areas for integration with R&D programmes

CHAPTER 5 OUTCOMES RESEARCH AND PRICING/REIMBURSEMENT ISSUES
5.1 Integration of outcomes research with pricing and reimbursement
5.2 Best practice applications of outcomes data in pricing and reimbursement
5.3 Outcomes research and health economics - problem areas for pricing and reimbursement issues

CHAPTER 6 OUTCOMES RESEARCH AND MARKETING
6.1 Integration of outcomes research into marketing programmes
6.2 The use of outcomes data in marketing
6.3 Outcomes research and health economics - problem areas for marketing
6.3.1 Industry survey

CHAPTER 7 THE POWER OF HEALTH ECONOMICS AND OUTCOMES RESEARCH METHODOLOGIES IN EARLY DRUG DEVELOPMENT
7.1 Introduction
7.2 Increasing corporate value
7.3 Portfolio management decisions
7.3.1 Price finding
7.3.2 Early consideration of customer issues
7.3.3 Logistics
7.3.4 Outsourcing early evaluations
7.4 Survey of early health economic and outcomes research methodologies currently used by industry
7.5 Macro-modelling
7.6 Recommendations
7.7 Conclusions

CHAPTER 8 PRACTICALITIES OF OUTCOMES RESEARCH
8.1 Introduction
8.2 Good Economic Evaluation Practice - tutorial software
8.3 Health economic guidelines
8.4 UK guidelines on good practice in the conduct of economic evaluations of medicine
8.5 Writing the report
8.6 The dissemination of outcomes research studies
8.7 To outsource or not to outsource?
8.8 Conclusions

CHAPTER 9 SOURCES AND ANALYSIS OF OUTCOMES DATA
9.1 Introduction
9.2 Collecting the right outcomes data
9.3 Types of outcomes data
9.4 Preparing for data collection
9.4.1 Literature searches
9.4.2 Meta analysis
9.4.3 The Delphi panel
9.5 Data sources
9.5.1 Epidemiological studies
9.5.2 Externally available patient databases
9.5.2.1 Claims databases
9.5.2.2 Medical record databases
9.5.2.3 Linked databases
9.6 Merits of the UK healthcare system for outcomes data
9.7 Incorporating outcomes research into randomized prospective clinical trials
9.8 Disease registries
9.9 Managing outcomes research and health economic information
9.9.1 Modelling of outcomes research and health economic studies
9.9.2 Decision trees
9.9.3 Outcomes modelling and decision tree software
9.9.3.1 DATA(tm) by TreeAge Software Inc
9.9.3.2 Other decision tree systems
9.10 The cost of outcomes data
9.11 Summary

CHAPTER 10 EXTERNAL SOURCES OF OUTCOMES DATA - COMMERCIAL
10.1 Introduction
10.2 The Degge Group Ltd
10.3 DIN-LINK
10.4 EPIC
10.5 Future HealthCare Inc
10.6 GPASS
10.7 HCIA Inc
10.8 Health Research Innovations (HRI)
10.9 IMS - Mediplus
10.10 IMS America Disease, Treatment and Outcomes Information Services
10.11 Medical Economics Company
10.12 MediQual Systems Inc
10.13 Medicine for the Elderly
10.14 MEDSTAT
10.15 MEMO (Tayside, Scotland database)
10.16 OHIP - Office of Health Information for Policy
10.17 OLGA: The On-Line Guide to Quality-of-Life Assessment
10.18 OSHPD - Healthcare Data Programs
10.19 Pangaea
10.20 Pharmametrics GmbH
10.21 PharMark Corporation (Arlington, VA) and euroPharMark Ltd (London)
10.22 The Qost(r) Database
10.23 QualityMetric Inc
10.24 Technology Assessment Group (TAG) - Disease Registries
10.25 Timely Data Resources

CHAPTER 11 EXTERNAL SOURCES OF OUTCOMES DATA - NON-PROFIT MAKING OUTCOMES AND PHARMACOECONOMIC ORGANISATIONS
11.1 Introduction
11.2 Centers for Disease Control and Prevention
11.3 Centre for Evidence-Based Medicine
11.4 The Center for Pharmaceutical Outcomes Research (CePOR)
11.5 Health Care Financing Administration (HCFA)
11.6 Health Data Research
11.7 International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
11.8 The Health Outcomes Institute
11.9 HELMIS: The Health Management Information Service
11.10 The Institute of Pharmaco-Economics
11.11 The Medical Outcomes Trust
11.12 Medical Technology and Practice Patterns Institute Inc (MTPPI)
11.13 NHS Centre for Reviews and Dissemination (at the University of York)
11.14 Office of Health Economics
11.15 Office of Health Policy and Clinical Outcomes
11.16 The Office for National Statistics (ONS)
11.17 RAND
11.18 Saskatchewan Epidemiology, Research & Evaluation Unit
11.19 Stratis Health
11.20 Utah Office of Health Data Analysis
11.21 UK Clearing House on Health Outcomes
11.22 European Clearing Houses on Health Outcomes (ECHHO)
11.23 University of Birmingham - Aggressive Research Intelligence Facility (ARIF)
11.24 US National Library of Medicine
11.25 WHOSIS (WHO Statistical Information System)
11.26 The World Wide Web Virtual Library

CHAPTER 12 THE PUBLICATION OF OUTCOMES RESEARCH STUDIES
12.1 Introduction
12.2 Assisted search methodogies in outcomes research
12.2.1 The Health Economic Evaluations Database (HEED)
12.2.2 Micromedex Inc
12.2.3 Adis International Ltd
12.3 Publication of outcomes research studies
12.3.1 Specialist journals dealing with health economics and outcomes research
12.3.2 Publishers
12.3.2.1 Adis International Ltd
12.3.2.2 MedStrategy
12.4 Relevant journals
12.4.1 British Journal of Medical Economics
12.4.2 Disease Management & Health Outcomes
12.4.3 Drugs & Therapy Perspectives
12.4.4 Evidence-Based Medicine
12.4.5 Health Economics
12.4.6 Health Outcomes in Europe
12.4.7 Health Policy, Economics and Management
12.4.8 Journal of Health Economics
12.4.9 Journal of Outcomes Research
12.4.10 Journal of Research in Pharmaceutical Economics
12.4.11 Medical Economics
12.4.12 The Medical Outcomes Trust
12.4.13 Office of Health Economics News
12.4.14 Office of Health Policy and Clinical Outcomes
12.4.15 PharmacoEconomics
12.4.16 PharmacoEconomics and Outcomes News
12.4.17 Pharmacoepidemiology and Drug Safety
12.4.18 Pharmacy Cost Control News
12.4.19 Quality of Life Research

CHAPTER 13 USEFUL E-MAIL AND INTERNET ADDRESSES AND E-MAIL ADDRESSES
13.1 E-mail addresses
13.2 Internet sites

CHAPTER 14 FROM CLINICAL RESEARCH TO CLINICAL OUTCOMES TO HEALTH ECONOMICS - THE BASICS
14.1 Introduction
14.2 Quality of life assessment
14.3 Constructing a decision/outcomes tree
14.3.1 Sensitivity analysis
14.3.2 Study logistics
14.4 Data for outcomes and economics assessments
14.5 Collecting data to demonstrate economic benefits
14.6 Choice of comparator
14.7 Health economic methodologies
14.7.1 Cost-minimisation analysis
14.7.2 Cost-effectiveness analysis
14.7.3 Cost-benefit analysis
14.7.4 Cost-utility analysis
14.8 The modelling of outcomes research and health economic information
14.9 Further reading

REFERENCES

PUBLISHED: MARCH 1998
REF: BS909E
PAGES: 247
PRICE: £520/$1,095/¥125,000